Westlake CORP 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
Westlake Corporation announced a substantial improvement in its second quarter 2026 financial results, driven by enhanced net income, EBITDA, and strategic operational improvements.
NYSE
Westlake Corporation announced significant legal victories as Dutch courts dismissed two major antitrust claims, though appeals are possible.
NYSE
Westlake Corporation announced the completion of its acquisition of a polyvinyl chloride and vinyl chloride monomer production site in Wilhelmshaven, Germany, expanding its global manufacturing footprint.
NYSE
Westlake Corporation's 2026 Annual Meeting saw the election of five directors, approval of executive compensation, and ratification of PricewaterhouseCoopers LLP as its auditor.
NYSE
Westlake Corporation announced its first quarter 2026 financial results, reporting a net loss impacted by litigation settlement and facility shutdown charges, while noting margin improvements in its Performance and Essential Materials segment due to geopolitical events.
NYSE
Westlake Corporation has appointed Jonathan H. Baksht as Senior Vice President and Chief Financial Officer, effective June 15, 2026.
NYSE
Westlake Corporation has reached a settlement agreement for $67 million in the PVC Pipe Antitrust Litigation concerning direct purchasers.
NYSE
Westlake Corporation has entered into a new $1.5 billion unsecured revolving credit facility, replacing its previous agreement.
NYSE
Westlake Corporation announced substantial net losses for Q4 and full year 2025, while outlining a comprehensive plan to improve EBITDA by $600 million in 2026 through footprint optimization, cost savings, and improved plant reliability.
NYSE
Westlake Corporation announced the election of two new directors to its board and the upcoming retirement of its Chief Financial Officer.
NYSE
Westlake Corporation announced the completion of its acquisition of ACI/Perplastic Group's global compounding solutions businesses, expanding its specialty materials portfolio and manufacturing presence.
NYSE
Westlake Corporation announces the closure of several North American production facilities, including PVC, VCM, chlor-alkali, and styrene plants, impacting 295 employees and incurring $415 million in pre-tax costs.
NYSE
Westlake Corporation announced the successful pricing and expiration of its cash tender offer for its 3.600% Senior Notes due 2026, repurchasing a significant portion of the outstanding debt.
NYSE
Westlake Corporation announced the pricing of a $1.2 billion senior notes offering to refinance existing debt and fund a pending acquisition.
NYSE
Westlake Corporation initiates a cash tender offer for its 2026 Senior Notes and proposes a new senior unsecured notes offering to refinance debt and fund an acquisition.
NYSE
Westlake Corporation announced a significant net loss of $782 million in Q3 2025, driven by a $727 million goodwill impairment in its North American Chlorovinyls business.
NYSE
Westlake Corporation announced an agreement to acquire the global compounding solutions businesses of the ACI/Perplastic Group, expanding its Housing & Infrastructure Products segment.
NYSE
Westlake Corporation reported a net loss of $142 million in Q2 2025, impacted by facility closures and production disruptions, despite sequential improvements in its Housing and Infrastructure Products segment.
NYSE
Westlake Corporation announced plans to cease all operations at its Pernis, Netherlands facility, expecting approximately EUR 190 million in pre-tax costs and a workforce reduction of 230 employees due to continued business deterioration in Europe.
NYSE
Westlake Corporation held its annual meeting of stockholders on May 8, 2025, and voted on the election of directors and the ratification of the appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm.
NYSE
Westlake Corporation's first quarter 2025 results were impacted by higher feedstock and energy costs, planned turnarounds, and unfavorable sales mix, leading to a net loss of $40 million.
NYSE
Westlake Corporation's Compensation Committee approved a special award of restricted stock units to Executive Vice President Robert F. Buesinger with a grant date fair value of $1.5 million.
NYSE
Westlake Corporation's Compensation Committee approved a special award of restricted stock units to CEO Jean-Marc Gilson with a grant date fair value of $1 million.
NYSE
Westlake Corporation reports solid sales volume growth and record Housing and Infrastructure Products (HIP) performance for 2024, offset by lower prices and margins in the Performance and Essential Materials (PEM) segment.
NYSE
Westlake Corporation has appointed Roger A. Cregg to its Board of Directors, succeeding Marius A. Haas, effective December 10, 2024.
NYSE
Westlake Corporation's third quarter 2024 results were impacted by extended maintenance outages and weather disruptions, leading to decreased earnings compared to the previous quarter.
NYSE
Westlake Corporation's Compensation Committee has approved changes to Albert Chao's compensation as he transitions to Executive Chairman, effective July 15, 2024.
NYSE
Westlake Corporation reported strong second quarter 2024 results, driven by record performance in its Housing and Infrastructure Products segment and improved profitability in its Performance and Essential Materials segment.
NYSE
Westlake Corporation plans to temporarily cease operations of its allyl chloride and epichlorohydrin units in Pernis, Netherlands, incurring approximately EUR 80 million in pre-tax costs.
NYSE
Westlake Corporation has appointed Jean-Marc Gilson as its new President and CEO, succeeding Albert Chao, who will become Executive Chairman.